Quince Therapeutics
IPOPublic · United States · $285.0M raised
- Business Model
- B2B
- Website
- quincetx.com
- Total Funding
- $285.0M
- Last Round
- $187.0M Corporate RoundJun 2024
- Rounds
- 4
- Type
- Public
About
Quince Therapeutics (fka Cortexyme) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases.
Summary
Quince Therapeutics is a Biotech company based in United States. It has raised $285.0M in total across 4 rounds, most recently a $187.0M Corporate Round round in Jun 2024. Investors include Sequoia Capital, Sofinnova Partners and Pfizer Venture Investments.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...